Commutee

Pfizer to spinoff, merge off-patent drugs unit with Mylan

July 29, 2019 by  
Filed under News

Pfizer Inc has agreed to spin off its off-patent branded drugs business and combine it with generic drugmaker Mylan NV , a move that leaves Pfizer with its more profitable innovative drugs, including cancer treatment Ibrance and pneumonia vaccine Prevnar.


Source: Reuters Business News

Comments are closed.